Home Unbiased and uncensored debate Vaccines ARPA-H: More mRNA Vaccines And Other Delivery Systems Planned – For You

  • ARPA-H: More mRNA Vaccines And Other Delivery Systems Planned – For You

     TheRealRestoreInc. updated 3 weeks, 6 days ago 1 Member · 3 Posts
  • TheRealRestoreInc.

    Member
    October 24, 2021 at 8:37 pm

    Prelude:Previous ARPA-H discussion described ambitious plans in the USA based on digital surveillance and mRNA platforms.

    Link:

    https://trialsitenews.com/forums/discussion/arpa-h-harpa-and-china-social-score-system/

    The following discusses the continuing attempt of imparting overreaching intrusion into your health freedom.

    Of course, there are pros and cons.

    Sources:

    https://www.theburningplatform.com/2021/07/27/u-s-on-course-to-become-digital-dictatorship-under-proposed-biomedical-research-agency/

    https://www.nih.gov/arpa-h/news-publications

    and

    https://www.whitehouse.gov/ostp/news-updates/2021/09/30/white-house-and-national-institutes-of-health-release-report-summarizing-the-listening-sessions-with-stakeholders-on-the-proposed-advanced-research-projects-agency-for-health/

    Pros:

    ARPA-H is proposed as a new component of NIH that will benefit the health of all Americans by catalyzing health breakthroughs that cannot readily be accomplished through traditional research or commercial activity. It will embrace bold and high-risk, high reward solutions with the potential to accelerate disruptive progress across an array of diseases and conditions and at levels ranging from the molecular to the societal. The goal of the listening sessions was to understand the opportunities and barriers to accelerating biomedical and health research breakthroughs from the perspectives of patient advocates, nonprofit and philanthropic organizations, professional societies, the academic research community, industry, and others.

    Cons:

    Story at-a-glance:

    President Biden is calling for a “new biomedical research agency” that would operate under the guise of treatments for chronic diseases, but which, if implemented, would merge national security with health security.

    The plan would suck up masses of private data from “Apple Watches, Fitbits, Amazon Echo and Google Home” and other consumer electronic devices, as well as information from health care providers to determine if an individual might be likely to commit a crime.

    The plan also would work toward merging “biology, engineering and computer science to harness the power of natural systems for national security” along with “advancements in biotechnology, supercomputing, big data and artificial intelligence” to accomplish its goals.

    In the interests of national safety, the Department of Defense wants everyone to have biometric wearables that could monitor 165 different biomarkers using an algorithm that could “recognize an infection or virus around 48 hours before the onset of symptoms.” Ultimately, promoters of the technology want to “develop tools to record, mark and manipulate precisely defined neurons in the living brain” that are determined to be linked to an “abnormal” function or a neurological disease.

    ARPA-H (HARPA) AND CHINA SOCIAL SCORE SYSTEM

  • TheRealRestoreInc.

    Member
    October 30, 2021 at 4:49 pm

    Testing nanodelivery of vaccine contents, not through a needle, but through food…and other off the deep end tech is already existent.

    Short trailer video

    This exclusive Greg Reese report exposes the sinister plan to incorporate nanotechnology into humanity’s food supply…

    https://bytehighway.net/c3bf825c85593df9a1b85db67fd1d86f/manifest/video.m3u8

  • TheRealRestoreInc.

    Member
    November 10, 2021 at 10:49 pm

    <div>THE ARPA TWINS IN FEDERAL GOVERNMENT…DELIBERATE ACRONYM DISSONANCE-INDUCING SPENDING
    </div><div>

    IS ARPA THE ADVANCED RESEARCH PROJECTS AGENCY OR IS IT THE AMERICAN RESCUE PLAN ACT?

    </div><div>

    117th CONGRESS
    1st Session

    </div><div>

    H. R. 5585

    To establish the Advanced Research Projects Agency–Health, and for other purposes.

    </div><div>

    https://www.congress.gov/bill/117th-congress/house-bill/5585/text?q=%7B%22search%22%3A%5B%22education%22%5D%7D&r=2&s=1

    Excerpts

    “PART J—Advanced Research Projects Agency–Health

    “SEC. 499A. Advanced Research Projects Agency–Health.

    “(a) Establishment.—There is established the Advanced Research Projects Agency–Health (in this part referred to as ‘ARPA–H’) within the Department of Health and Human Services.

    “(b) Goals and activities.—

    “(1) GOALS.—The goals of ARPA–H shall be to—

    “(A) foster the development of new, breakthrough capabilities, technologies, systems, and platforms to accelerate innovations in health and medicine;

    “(B) revolutionize diagnosis, mitigation, prevention, and treatment of diseases through the development of transformative health technologies and high-need cures;

    “(C) promote high-risk, high-reward innovation to develop high-need cures; and

    “(D) ensure the United States maintains—

    “(i) global leadership in science and innovation; and

    “(ii) the highest quality of life and health for its citizens.

    “2) MEANS.—ARPA–H shall achieve the goals under paragraph (1) by—

    “(A) identifying and promoting revolutionary advances in health sciences;

    “(B) translating scientific discoveries into technological innovations and high-need cures;

    “(C) providing resources and support to create platform capabilities that draw on multiple disciplines;

    “(D) delivering advanced proofs of concept that demonstrate clinically meaningful advances;

    “(E) accelerating transformational technological advances in areas with limited funding or technical certainty; and

    “(F) prioritizing investments based on such considerations as—

    “(i) scientific opportunity and uniqueness of fit to the strategies and operating practices of ARPA–H;

    “(ii) the effect on disease burden, including unmet patient need and the fiscal liability of the Federal Government with respect to health care; and

    “(iii) potential opportunities to advance health equity.

    “(c) Director.—

    “(1) IN GENERAL.—The President shall appoint in the Department of Health and Human Services a director of ARPA–H (in this section referred to as the ‘Director’).

    “(2) QUALIFICATIONS.—The Director shall be an individual who, by reason of professional background and experience, is especially qualified to manage—

    “(A) research and advanced development programs; and

    “(B) large-scale, high-risk initiatives with respect to health research across multiple sectors, including generating high-need cures.

    “(3) RELATIONSHIP TO SECRETARY.—The Director shall report to the Secretary.

    “(4) DUTIES.—The duties of the Director shall include the following:

    “(A) Approve and terminate the projects and programs of ARPA–H.

    “(B) Set research and development priorities with respect to the goals under subsection (b) and manage the budget of ARPA–H.

    “(C) Develop funding criteria and assess the success of programs through the establishment of technical milestones.

    “(D) Advance the goals under subsection (b), through consideration of the advice of the ARPA–H Interagency Advisory Committee established under subsection (l).

    “(E) Solicit data, as needed, from the National Institutes of Health and other relevant Federal agencies, private entities, academia, nonprofit organizations, and international organizations.

    “(F) Coordinate with the Director of the National Institutes of Health to ensure that the programs of ARPA–H build on and are informed by scientific research supported by the National Institutes of Health.

    “(G) Coordinate with the heads of Federal agencies and, to the extent practicable, ensure that the activities of ARPA–H supplement (and do not supplant) the efforts of other Federal agencies.

    “(5) TERM.—The Director—

    “(A) shall be appointed for a 5-year term; and

    “(B) may be reappointed for 1 consecutive term.

    “(6) AUTONOMY OF AGENCY REGARDING RECOMMENDATIONS AND TESTIMONY.—No officer or agency of the United States shall have any authority to require the Director or any other officer of ARPA–H to submit legislative recommendations, or testimony or comments on legislation, to any officer or agency of the United States for approval, comments, or review prior to the submission of such recommendations, testimony, or comments to the Congress, if such recommendations, testimony, or comments to the Congress include a statement indicating that the views expressed therein are those of the Director or such officer, and do not necessarily reflect the views of the President or another agency.

    “(7) DELEGATION OF AUTHORITY.—The Director may delegate to any duly authorized employee, representative, or agent any power vested in the Director or ARPA–H by law, except that the Director may not delegate the power to appoint the Deputy Director under paragraph (8).

    “(8) DEPUTY DIRECTOR.—The Director shall appoint a deputy director to serve as acting Director in the absence or unavailability of the Director (notwithstanding section 3345 of title 5, United States Code).

    “(d) Application of Paperwork Reduction Act.—The Director may waive the requirements of subchapter I of chapter 35 of title 44, United States Code (commonly referred to as the ‘Paperwork Reduction Act’) with respect to the activities described under subsection (c)(3)(F).

    “(e) Partnerships.—In carrying out this section, the Director may partner with public and private entities, including—

    “(1) other Federal agencies;

    “(2) institutions of higher education;

    “(3) private or public research institutions;

    “(4) federally funded research and development centers;

    “(5) private entities, including biotechnology, and pharmaceutical, medical device, and other health entities; and

    “(6) nonprofit organizations, including patient advocacy groups.

    “(f) Coordination on high-Need cures.—The Director shall coordinate with the Commissioner of Food and Drugs and the Administrator of the Centers for Medicare & Medicaid Services to expedite the development, application, coverage, and implementation of high-need cures.

    “(g) Awards.—In carrying out this section, the Director may make awards in the form of grants, contracts, cooperative agreements, prizes, and other transactions, including—

    “(1) grants and cooperative agreements subject to the uniform administrative requirements, cost principles, and audit requirements for Federal awards contained in part 200 of title 2 of the Code of Federal Regulations;

    “(2) contracts subject to chapter 1 of title 48, Code of Federal Regulations (or successor regulations) (commonly referred to as the ‘Federal Acquisition Regulation’) but exempt from the regulations specified in chapter 3 of title 48, Code of Federal Regulations (or successor regulations);

    “(3) multi-year contracts under section 3903 of title 41, United States Code;

    “(4) prize competitions; and

    “(5) other transactions or prototype projects that are directly relevant to enhancing such goals.

    “(h) Facilities authority.—The Director may—

    “(1) acquire (by purchase, lease, condemnation or otherwise), construct, improve, repair, operate, and maintain such real and personal property necessary to carry out this section; and

    “(2) lease an interest in property for not more than 20 years, notwithstanding section 1341(a)(1) of title 31, United States Code.

    “(i) Personnel.—

    “(1) IN GENERAL.—The Director of ARPA–H shall have the authority to—

    “(A) hire personnel under section 207(f) and establish governing criteria to recruit, appoint, and compensate personnel under this section without regard to any provision in title 5, United States Code, governing appointments under the civil service laws and fix the compensation of such personnel at a rate to be determined by the Director, up to the amount of annual compensation (excluding expenses) specified in section 102 of title 3, United States Code, notwithstanding section 202 of the Department of Health and Human Services Appropriations Act, 1993 (Public Law 102–394) or any provision of title 5, United States Code, governing the rates of pay or classification of employees in the executive branch;

    “(B) make additional appointments of scientific, medical, and professional personnel under this section without regard to any provision in title 5, United States Code, governing appointments under the civil service laws and fix the compensation of such personnel at a rate to be determined by the Director, up to the amount of annual compensation (excluding expenses) specified in section 102 of title 3, United States Code, notwithstanding section 202 of Department of Health and Human Services Appropriations Act, 1993 (Public Law 102–394) or any provision of title 5, United States Code, governing the rates of pay or classification of employees in the executive branch; and

    “(C) make appointments to positions of administration or management of ARPA–H without regard to any provision in title 5, United States Code, governing appointments under the civil service laws and fix the compensation of such personnel at a rate to be determined by the Director, up to the amount of annual compensation (excluding expenses) specified in section 102 of title 3, United States Code, notwithstanding section 202 of Department of Health and Human Services Appropriations Act, 1993 (Public Law 102–394) or any provision of title 5, United States Code, governing the rates of pay or classification of employees in the executive branch.

    “(2) ADDITIONAL STAFF.—The Director of ARPA–H may use all authorities in existence on the date of enactment of this section that are provided to the Secretary to hire administrative, financial, legal, contracts, legislative affairs, and information technology staff, and such other staff as may be identified by the Director as necessary to carry out this section.

    “(3) ADDITIONAL CONSIDERATIONS.—In appointing qualified personnel under this subsection, the Director—

    “(A) may contract with private entities; and

    “(B) shall make efforts to recruit and retain a diverse workforce, including individuals underrepresented in science and medicine and racial and ethnic minorities.

    “(4) ADDITIONAL HIRING AUTHORITY.—To the extent needed to carry out the duties in paragraph (1), the Director is authorized to utilize hiring authorities under section 3372 of title 5, United States Code, to staff ARPA–H with employees from other Federal agencies, State and local governments, Indian Tribes and Tribal organizations, institutions of higher education, and other organizations, as described in that section, in the same manner and subject to the same conditions, that apply to such individuals utilized to accomplish other purposes.

    “(5) EXISTING AUTHORITIES.—The authorities granted by this section are—

    “(A) in addition to existing authorities granted to the Secretary; and

    “(B) are not intended to supersede or modify any existing authorities.

    “(j) Program managers.—

    “(1) IN GENERAL.—The Director shall designate employees of ARPA–H to serve as program managers for the programs carried out by ARPA–H.

    “(2) DUTIES.—A program manager shall—

    “(A) establish research and development goals for programs in accordance with guidance from the Director;

    “(B) collaborate with experts from the National Institutes of Health and other Federal agencies and experts in relevant scientific fields to identify research and development opportunities;

    “(C) convene workshops, as needed, with relevant Federal agencies, institutions of higher education, nonprofit research institutions, companies, venture capital firms, and nonprofit organizations for the development of high-need cures;

    “(D) issue funding opportunity announcements;

    “(E) select, on the basis of merit, each of the projects to be supported under a program carried out by ARPA–H, taking into consideration—

    “(i) the novelty and scientific and technical merit of the proposed projects;

    “(ii) the demonstrated capabilities of the applicants to successfully carry out the proposed project;

    “(iii) the unmet needs within patient populations;

    “(iv) the consideration by the applicant of future commercial applications of the project, including the feasibility of partnering with one or more commercial entities; and

    “(v) such other criteria as are established by the Director;

    “(F) identify milestones and monitor progress of such milestones with respect to each project;

    “(G) provide recommendations to the Director with respect to advancing the goals under subsection (b);

    “(H) identify opportunities for the commercial application of successful projects, including through the establishment of partnerships between or among awardees; and

    “(I) provide recommendations to expand, restructure, or terminate research partnerships or projects.

    “(3) TERM.—A program manager may serve not greater than 2 terms for a period of 3 years each.

    https://www.dol.gov/general/american-rescue-plan

    Shown Here:
    Public Law No: 117-2 (03/11/2021)

    American Rescue Plan Act of 2021

    This bill provides additional relief to address the continued impact of COVID-19 (i.e., coronavirus disease 2019) on the economy, public health, state and local governments, individuals, and businesses.

    </div>

Viewing 1 - 3 of 3 replies

Original Post
0 of 0 posts June 2018
Now